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Vacuole biogenesis depends on specific targeting and retention of
peripheral membrane proteins. At least three palmitoylated pro-
teins are found exclusively on yeast vacuoles: the fusion factor
Vac8, the kinase Yck3, and a novel adaptor protein implicated in
microautophagy, Meh1. Here, we analyze the role that putative
acyltransferases of the DHHC family play in their localization and
function. We find that Pfa3Ynl326c is required for efficient local-
ization of Vac8 to vacuoles in vivo, while Yck3 or Meh1 localization
is not impaired in any of the seven DHHC deletions. Vacuole-
associated Vac8 appears to be palmitoylated in a pfa3 mutant, but
this population is refractive to further palmitoylation on isolated
vacuoles. Vacuole morphology and inheritance, which both de-
pend on Vac8 palmitoylation, appear normal, although there is a
reduction in vacuole fusion. Interestingly, Pfa3 is required for the
vacuolar localization of not only an SH4 domain that is targeted by
myristatepalmitate (as in Vac8) but also one that is targeted by a
myristatebasic stretch (as in Src). Our data indicate that Pfa3 has
an important but not exclusive function for Vac8 localization to the
vacuole.
Yck3  SH4 domain  acylation  membrane targeting
Protein and lipid trafficking along the endomembrane systemoccurs by vesicular transport (1). Of all proteins implicated
in vesicle fusion and fission, only a subset is permanently
associated with membranes via transmembrane segments,
whereas most are recruited to the membrane from the cyto-
plasm. The latter proteins depend on membrane receptors,
lipids, or lipid anchors for binding to their appropriate target
membrane (2). This poses the question of how the recruitment
of these proteins is coordinated with their function.
Palmitoylation has been discussed as a special lipid modifica-
tion. It may direct proteins to specific membrane domains (3–5),
and it is the only common lipid modification that is reversible,
permitting cycling of a protein between membranes and cytosol.
The identification and characterization of the underlying acyla-
tiondeacylation machinery is therefore critical for understand-
ing the function of palmitoylation. Recently, biochemical and
genetic analyses have identified several proteins that are re-
quired for palmitoylation, including those of the so-called
DHHC-CRD family of polytopic membrane proteins (6). Yeast
contains seven homologs (Erf2, Swf1, Yol003c, Akr1, Akr2,
Ydr459c, and Ynl326cPfa3), which seem to be distributed
throughout the endomembrane system as suggested by the GFP
database and recent studies. At the ER, Swf1 is required for
palmitoylation of Tlg1 (7), and Erf2 promotes Ras2 palmitoyl-
ation (8, 9). The Golgi-localized Akr1 is responsible for palmi-
toylation of the casein kinase I (CKI) isoform Yck2 (10).
Similarly, several of the 20 or so mammalian DHHC proteins
localize to distinct organelles, with critical roles for the palmi-
toylation of PSD-95, Ras, and SNAP-25 (11–13). This wide
distribution of proteins involved in palmitoylation suggests that
palmitoylation is not restricted to one organelle but may occur
at multiple sites.
We are interested in protein palmitoylation at the yeast
vacuole. The fusion factor Vac8 is myristoylated at the N-
terminal glycine and palmitoylated at up to three N-terminal
cysteines (called SH4 domain). Palmitoylation is observed dur-
ing the in vitro fusion of purified vacuoles and is required for
Vac8’s function in fusion and inheritance (14) (K.S., L.E.P.D.,
H.H., T.J.L., and C.U., unpublished work). Another regulator of
vacuole fusion, the CKI isoform Yck3, is tail-anchored to
vacuoles through palmitoylation of a cysteine string-like motif
(15, 16). Recently, a third palmitoylated vacuolar protein, Ego1
Meh1, was identified as a factor involved in microautophagy
(refs. 17 and 18 and our unpublished observations). Whereas
most of Yck3 seems to be palmitoylated before its sorting to the
vacuole (15), a large proportion of Vac8 can be palmitoylated on
vacuoles. We have previously shown that the SNARE Ykt6 is
involved in palmitoylation of vacuole-associated Vac8. Antibod-
ies to Ykt6 block Vac8 palmitoylation, and purified Ykt6 can
support in vitro palmitoylation of Vac8 when present in stoichi-
ometric amounts (19). To search for additional factors involved
in palmitoylation of vacuolar proteins, we determined whether
any of the sevenDHHC proteins are required for the localization
and palmitoylation of Vac8, Yck3, or Meh1Ego1. Here, we
present evidence that the vacuolar DHHC protein Ynl326c
contributes to the localization of Vac8 and affects palmitoyl-
ation, but not localization, of Yck3. No single DHHC protein
could be identified that is responsible for Yck3 or Meh1Ego3
localization. Importantly, Ynl326c deletion does not completely
abolish Vac8’s sorting, palmitoylation, and function, indicating
that its membrane association involves multiple factors, includ-
ing two factors that affect its palmitoylation.
Methods
Yeast Strains and Molecular Biology. BY4741 yeast strains (MATa
his3 leu2 met15 ura3) with deletions in the DHHC genes
(erf2, akr1, akr2, ydr459c, yol003c, swf1, pfa3) were
purchased from EUROSCARF (Frankfurt). Deletions in pfa3 in
BJ3505 (MATa pep4::HIS3 prb1-1.6RHIS3 lys2–208 trp1101
ura3–52 gal2 can) and DKY6281 (MAT leu2–3 leu2–112
ura3–52 his3-200 trp1-101 lys2–801 suc2-9 pho8::TRP1)
were generated by transforming PCR products that introduce a
URA3 (BJ) or a HIS3 (DKY) marker into the PFA3 locus. Loss
of the gene was confirmed by PCR. To facilitate screening for
Yck3, a pRS416-NOP1pr-GFP-YCK3 plasmid (16) was intro-
duced into the BY4741 deletion strains. Vac8 was tagged
genomically at the C terminus with GFP by using pYM29 (20)
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as a template for PCR, followed by selection on yeast extract
peptonedextrose (YPD) plus geneticin. Pfa3 was tagged with
the TAP tag by using a similar approach and the same selection
procedure. N-terminal tagging of Yck3 with GFP in BJ3505 was
done by PCR amplifying a TRP1-PHO5pr-GFP-Myc cassette
that replaced the endogenous promoter (21). Introduction of a
galactose-inducible promoter in front of the YCK3 ORF in
BJ3505 was as described in ref. 16. pRS426 plasmids containing
the N-terminal domain of Vac8 or the Src kinase fused to GFP
[Vac8-(1–18)-GFP and Src-(1–16)-GFP] under the control of a
NOP1 promoter are from unpublished work (K.S., L.E.P.D.,
H.H., T.J.L., and C.U.) or were generated by introducing a
sequence coding for the first 18 aa of the Leishmania protein
HASPB [hydrophilic acylated cell surface protein B (22)] with a
T6S mutation to allow for myristoylation of the protein into the
same vector (our unpublished observations).
Microscopy. Fluorescence microscopy and FM4–64 staining of
yeast cells was done as described in ref. 16 and 23. Brief ly, yeast
cells were grown to OD600  0.5, then incubated with 50 M
FM4–64 for 1 h, washed twice with medium, and chased for
3 h before being analyzed by f luorescence microscopy. Filter-
sterilized synthetic mediumdextrosecomplete medium was
used for GFP fluorescence of cells grown to mid-log phase.
Images were acquired with a Zeiss Axiovert 35 microscope
equipped with an AxioCam [filter set 10 (for GFP) or 23
(for FM4–64), 100 objective] and were processed by using
PHOTOSHOP 7.0.
Vacuole Purification and Fusion Assay. Vacuoles were purified and
analyzed for fusion as reported in ref. 24. Vacuoles from each
tester strain (3 g each, 30-l total volume) were incubated for
the indicated time at 26°C in reaction buffer (125mMKCl5mM
MgCl220 mM PipesKOH, pH 6.8200 mM sorbitol), a pro-
tease inhibitor mixture (PIC) (7.5 M pefabloc SC7.5 ng/ml
leupeptin3.75 M o-phenanthroline37.5 ng/ml pepstatin), and
an ATP-regenerating system. One unit of fusion activity equals
1 mol of p-nitrophenol phosphate hydrolyzed per min per g
pep4 vacuoles at 30°C.
Biochemical Fractionation of Yeast Cells and Vacuoles. Subcellular
fractionation and analyses of membrane association were done
as described in refs. 16 and 25 (K.S., L.E.P.D., H.H., T.J.L., and
C.U., unpublished work). Proteins were analyzed by SDSPAGE
and Western blotting.
Biotinylation Assay. To detect endogenously palmitoylated pro-
teins, a recently developed protocol was applied (7, 26). Cells (20
OD600 units) from a logarithmically grown culture were pelleted
and resuspended in 300l of lysis buffer [PBSprotease inhibitor
mixture (Roche)5 mM EDTA]. Cells were broken by the
addition of 100 l of 0.5-mm glass beads with a cell disrupter (4
min at 4°C). Samples were centrifuged (300  g for 5 min),
supernatants were removed, and the pellet was reextracted. One
milligram of pooled supernatants was then incubated with lysis
buffer (600 l) containing 1% Triton X-100 and 25 mM N-
ethylmaleimide to quench free cysteines (30 min at 4°C), and
proteins were precipitated with methanolchloroform. The air-
dried pellet was resuspended in 100 l of resuspension buffer
(2% SDS8 M urea100 mM NaCl50 mM TrisHCl, pH 7.4) by
sonication, diluted with 600 l of 1 M hydroxylamine (pH 7.4)
and 300 M biotin-BMCC (Pierce), and rotated for 2 h at 4°C.
As a control, hydroxylamine was replaced by PBS. Proteins were
then precipitated with methanolchloroform, dried, and resus-
pended by sonication as before. Lysis buffer with 0.1% Triton
X-100 (1 ml) was added to each sample, aliquots (60 l) were
removed as loading control, and the remaining reactions were
incubated with 100 l of neutravidin-agarose beads (Pierce) for
1 h at room temperature on a nutator. Neutravidin beads were
washed with PBS containing 0.5 M NaCl and 0.1% Triton X-100
and then once with PBS. Proteins were eluted by boiling for 5
min in 20 l of resuspension buffer containing 4 SDS sample
buffer lacking 2-mercaptoethanol. Samples were analyzed by
SDSPAGE and Western blotting.
Palmitoylation of Proteins on Isolated Vacuoles. Vacuoles from the
respective strains (60 g) were incubated in fusion reaction
buffer without ATP and with [3H]Pal-CoA (27). After 10 min,
vacuoles were collected (12,000  g for 10 min), resuspended in
SDS sample buffer without reducing agents, and analyzed by
SDSPAGE and fluorography.
Results
Identification of a Vacuolar DHHC Protein with a Role in Vac8 Local-
ization. To assess the possible contribution of DHHC proteins to
the localization of palmitoylated vacuolar proteins, we analyzed
the subcellular localization of Vac8, Meh1Ego3, and Yck3 in all
DHHC deletion strains by subcellular fractionation or fluores-
cence microscopy. In wild-type cells, all three proteins are found
in the vacuole-enriched membrane fraction (Fig. 1A, P, Vac8
and Meh1) or are observed on vacuoles (GFP-Yck3; Fig. 1A).
Presence in the supernatant fraction (S) is then indicative of a
defective localization of the respective protein. Whereas neither
Yck3 nor Meh1Ego3 are affected by any single DHHC deletion
mutant, Vac8 was mislocalized to the supernatant fraction in the
ynl326cpfa3 mutant (Fig. 1A). The strength of this defect
depends on the strain background: In the EUROSCARF back-
ground (BY4741; Fig. 1A), we observed a stronger defect than
when we created the ynl326cpfa3 deletion in the vacuole
protease-deficient BJ3505 tester strain, where 50% of Vac8
was membrane-localized (Fig. 1B). A similar Vac8 localization
like in the BJ strain was also observed in the second tester strain,
DKY6281 (data not shown). To be able to directly assess
function in vacuole fusion, to avoid proteolysis, and to allow
comparison with several of our Vac8 mutants, we selected the BJ
background for further studies and, if possible, compared it with
the BY background. We confirmed that Vac8 in the nonvacuolar
fraction was indeed soluble in ynl326cpfa3 cells, because it was
recovered in the supernatant after high-speed centrifugation
(Fig. 1B). Interestingly, we observed a slight size shift between
membrane-associated and soluble Vac8. To explore whether this
mobility shift reflected differences in the palmitoylation state of
the membrane-associated and soluble forms, we analyzed Vac8’s
mobility on lower percentage gels, comparing ynl326c and wild
type. We found that each contained both Vac8 forms, with the
upper band being exclusively in the membrane fraction. Dou-
blets were lost if samples were boiled in gel loading buffer
containing a reducing agent (Fig. 1C), suggesting that Vac8 is
still palmitoylated on membranes in ynl326c cells. Yck3 local-
ization was similar in both strains (Fig. 1 A–C and E). While this
study was under way, Linder and colleagues (28) reported a
function of Ynl326c in Vac8 palmitoylation. Because they
termed the protein Pfa3 (protein fatty acyltransferase 3), we will
refer to this name hereafter.
Effect of pfa3 Deletion on Vacuole Morphology and Inheritance. Pfa3
is localized to the vacuole (http:yeastgfp.ucsf.edu) and is
therefore an ideal candidate to be involved in palmitoylation of
Vac8. We analyzed GFP-tagged Vac8 in BJ wild-type and pfa3
cells by fluorescence microscopy. In agreement with our previ-
ous observations (Fig. 1), Vac8-GFP was exclusively found on
vacuoles in wild-type cells but, consistent with our fractionation
data, showed a significant cytosolic staining in pfa3 cells (Fig.
1D). This partial mislocalization is in contrast to the exclusively
cytosolic presence of a Vac8 mutant, in which all three SH4-
domain cysteines have been mutated (29) (K.S., L.E.P.D., H.H.,
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T.J.L., and C.U., unpublished work). Furthermore, vacuole
morphology was not affected in pfa3 cells (Fig. 2A). However,
we note that again, consistent with the strain-dependent differ-
ences in Vac8 fractionation, pfa3 vacuoles in BY were partially
fragmented, as were akr1 and akr2 cells (Fig. 1A). It is
presently unclear whether either akr1 or akr2 deletion affects
palmitoylation of vacuolar proteins. It is noteworthy that BY
strains have in general more vacuoles than our tester strains.
Loss of Vac8 or a mutation of all target cysteines in the SH4
domain (Cys) leads to complete vacuole fragmentation (Fig.
2B). Moreover, when we scored pfa3 for vacuole inheritance,
we observed only a 10–20% defect in either BJ or BY cells,
whereas cells lacking Vac8 or the Vac8 Cys mutant are com-
pletely deficient in vacuole inheritance (Fig. 2C) (29) (K.S.,
L.E.P.D., H.H., T.J.L., and C.U., unpublished work). These data
suggest that Pfa3 plays an important, but not exclusive, role in
Vac8’s localization to the vacuole. Because vacuole inheritance
requires Vac8 palmitoylation (K.S., L.E.P.D., H.H., T.J.L., and
C.U., unpublished work), it is possible that other proteins, such
as Ykt6, compensate sufficiently for the lack of Pfa3.
Pfa3 Affects Vacuole Fusion and Vac8 Palmitoylation. Vac8 requires
palmitoylation for localization to vacuoles, vacuole inheritance,
and efficient participation in the fusion reaction. We therefore
analyzed the role of Pfa3 in in vitro vacuole fusion. We deleted
PFA3 from both tester strains and used them in the fusion
reaction (30). Vacuoles lacking Pfa3 showed a 50% reduction in
fusion (Fig. 3A), consistent with a defective Vac8 localization
(Fig. 1). However, fusion is still functional if Vac8 is partially
localized (K.S., L.E.P.D., H.H., T.J.L., and C.U., unpublished
work), indicating that Pfa3 is likely to affect additional proteins
beside Vac8. In addition, fusion was still sensitive to all inhibitors
of the fusion reaction, including Ykt6 and Vac8 antibodies (Fig.
Fig. 1. Analysis of the DHHC mutants for Vac8 and Yck3 localization. (A
Upper) Subcellular fractionation. Cells from the respective deletion strains
(BY4741, EUROSCARF) were lysed and separated by centrifugation (13,000
g for 10 min at 4°C) into a pellet (P) and supernatant fraction (S) as described
in Methods. Proteins were analyzed by SDSPAGE and Western blotting with
antibodies to Meh1, Vac8, and Rpl3, a ribosomal subunit. (A Lower) The
indicated strains expressing GFP-Yck3 were analyzed by fluorescence micros-
copy. (B) Subcellular fractionation in BJ3505 cells. The lysate was centrifuged
for 10 min at 20,000g to yield the P20 and S20 fractions. To get the P100 and
S100 fractions, a similar amount of the S20 fraction was spun again (100,000
g for 30 min at 4°C). Proteins in pellet and TCA-precipitated supernatant were
analyzed by SDSPAGE and Western blotting. (C) Mobility of Vac8 on gels.
Subcellular fractionation was done as in B. Proteins were boiled in sample
buffer with or without 2-mercaptoethanol and analyzed by SDSPAGE and
Western blotting with antibodies to Vac8 and Yck3. The top band in the Yck3
illustration corresponds to Vac8, which was detected before Yck3. (D and E)
Localization of GFP-tagged Vac8 and Yck3 in BJ wild-type and pfa3 cells.
Yeast strains expressing the indicated GFP variant were analyzed by fluores-
cence microscopy.
Fig. 2. Vacuole morphology and inheritance. (A and B) Vacuoles from the
indicated BJ wild-type, pfa3, vac8, and the Cys-mutant, which expresses a
Vac8 mutant lacking the N-terminal cysteines (Cys is Vac8-C4,5,7A) were
stained with 50 M FM4–64 and observed by fluorescence microscopy. (C)
Vacuole inheritance was scored for the indicated strains as described in
Methods.
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3B), and was stimulated in either case by palmitoyl-CoA (Fig.
3C). Previously, we reported that Vac8 palmitoylation occurs in
an early subreaction on vacuoles that is sensitive to antibodies to
Sec18 and Ykt6 (14, 19). We therefore incubated vacuoles with
[3H]Pal-CoA and analyzed Vac8 palmitoylation. Only on wild-
type vacuoles did we observe efficient palmitoylation (Fig. 3D);
pfa3 vacuoles did not show labeling of Vac8. To find out
whether the lack of palmitoylation on pfa3 vacuoles is Vac8-
specific, we analyzed cells in which Yck3 is overexpressed, which
is required to detect its in vitro palmitoylation (16). Although
palmitoylation of both Vac8 and Yck3 was clearly detectable in
the Yck3 overexpression background, neither protein was la-
beled in the absence of Pfa3. Because Yck3 is localized to
vacuoles in pfa3 cells (Fig. 1), it is possible that overexpression
allows us to monitor a vacuolar palmitoylation event that does
not normally occur. In wild-type or pfa3 cells, most Yck3 might
already be palmitoylated before reaching the vacuole; the cur-
rent model is that this also requires the DHHC protein Akr1 at
the Golgi (15). When Yck3 is overexpressed, some of it might be
recruited directly from the cytoplasm to the vacuole, where it
would then become a substrate for Pfa3-dependent palmitoyl-
ation. Consistent with this possibility, we found that truncated
forms of Yck3 that lack its C-terminal cysteines only become
vacuole-localized when overexpressed (unpublished observa-
tions). Intriguingly, we also found that Yck3 is also sorted to
vacuoles when akr1 has been deleted (Fig. 1A), suggesting that
Akr1 and Pfa3 play compensatory roles in Yck3 palmitoylation.
Vac8’s palmitoylation might similarly be affected by multiple
proteins, i.e., Pfa3 and Ykt6. To determine whether the lack of
in vitro Vac8 palmitoylation in pfa3 is due to its inaccessibility
at the vacuole, we conducted an experiment to detect its
endogenous palmitoylation state using the biotin-switch method.
For this, proteins were first incubated with N-ethylmaleimide to
quench free cysteines, and then treated with hydroxylamine
to cleave the thioester. The free cysteine was then crosslinked to
biotin, and proteins were collected by neutravidin pull-down.
Our data indicate that Vac8 palmitoylation is detectable in
wild-type but severely reduced in pfa3 cells (Fig. 3E). We
therefore conclude that Pfa3 is important for Vac8 palmitoyl-
ation on vacuoles, which could then explain the fusion defect.
These results are not, however, consistent with the presence of
a significant portion of Vac8 on pfa3 vacuoles. Is Vac8 attached
to vacuoles through protein–protein interactions rather than
palmitoylation? Or is it possible that the Biotin-switch method
Fig. 3. Functional analysis of pfa3 deletion. (A) Vacuole fusion. Vacuoles from tester strains with the respective deletion were incubated at 26°C for 90 min
and then analyzed for fusion (SD, n 3). Fusion deficiency is stronger in the DKY background than in BJ (not shown). For details see Methods. (B) Sensitivity to
inhibitors. Fusion was analyzed as in A in the presence or absence of the indicated antibodies. All antibodies were titrated into the reaction (not shown), and
the strongest inhibition is shown. In general, antibody concentration was at 100 gml. For Gdi1, the inhibitor was boiled to determine the buffer control.
The control reaction was set to 100% for each combination. For additional information, see ref. 16. (C) Effect of Pal-CoA on fusion. Increasing Pal-CoA amounts
were titrated into the fusion reaction, and fusion was determined as before. (D) Palmitoylation of Vac8 and Yck3 on vacuoles. Purified vacuoles (60 g) from
the respective strain were incubated in fusion reaction buffer with [3H]Pal-CoA for 10 min at 26°C. Vacuoles were then collected (12,000 g for 10 min at 4°C),
and proteins were analyzed by SDSPAGE and fluorography. (E) Palmitoylation determined by the biotin-switch method. The indicated cells were lysed, free
cysteines were quenched by N-ethylmaleimide, and the extract was subjected to the biotin-switch procedure by using hydroxylamine (HA) and biotin-BMCC as
a crosslinker. Crosslinked proteins were captured on Neutravidin agarose (Pierce), eluted by boiling, and analyzed by SDSPAGE. Western blots were decorated
with antibodies to Vac8. Total (6%) refers to the faction of lysate removed before the Neutravidin pull-down. (F) Membrane association of Vac8. Vacuoles from
the indicated strains (30 g each) were diluted into 500 l of 20 mM HepesKOH (pH 7.4), 1 mM PMSF, and the following conditions: 0.1 M Na2CO3 (carb.), 6 M
urea, 1 M NaCl, or 1% Triton X-100, and incubated for 30 min on ice. Samples were then centrifuged (100,000 g for 30 min at 4°C) and split into pellet (P) and
supernatant (S). An aliquot corresponding to the membrane fraction used in each condition is shown for comparison (T). Proteins in pellet and TCA-precipitated
supernatant were analyzed by SDSPAGE and Western blotting. (G) Sizing of Pfa3. Vacuoles (200 g) from BJ3505 carrying Pfa3-TAP were incubated for 10 min
at 4°C in lysis buffer (20 mM TrisHCl, pH 7.4150 mM NaCl0.5% Triton X-1001 PIC), insoluble material was removed by centrifugation (20,000 g for 10 min
at 4°C), and the detergent extract was loaded onto a linear 10–30% glycerol gradient prepared in lysis buffer. The sample was then centrifuged (40,000 rpm in
an SW40 rotor for 18 h at 4°C), 0.5-ml samples were collected from the top of the gradient, and TCA-precipitated proteins were analyzed by SDSPAGE and
Western blotting. The first 10 samples are shown. Vps41 (120 kDa) is the only protein that had a second peak at the bottom of the gradient (not shown); the
SNARE Nyv1 (30 kDa) is found in a complex at 10S as part of the SNARE complex (26). (H) Physical associations. The detergent lysate from a BJ Pfa3-TAP strain
expressing Vac8(1–18)-GFP was prepared as in G and incubated with IgG beads overnight at 4°C. Load (L) and flow-throw (FT) (1% each) were removed, and
proteins were TCA-precipitated. Beads were washed two times in lysis buffer. Proteins were then eluted by boiling in sample buffer and analyzed as before. A
BJ vac8 strain expressing Vac8-GFP (WT*) served as a negative control. The lower band in the Vac8 illustration is due to the Pfa3-TAP signal, which runs at a
similar molecular weight.
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fails to detect certain palmitates if the thioester is rapidly
reversed during cell lysis, and some Vac8 is indeed palmitoylated
on pfa3 vacuoles? We therefore analyzed Vac8’s hydrophobic
properties by subjecting wild-type and pfa3 vacuoles to extrac-
tion with carbonate, urea, or salt, and found that, in all cases, at
least 50% of Vac8 remained membrane-associated (Fig. 3F).
Only with Triton X-100 was most Vac8 released into the soluble
fraction, a result that is typical for integral membrane proteins
(like the SNARE Vti1). As a control, the peripheral membrane
protein Sec17 was extracted to the supernatant fraction in either
case. Thus, Vac8 behaves like a hydrophobic (Fig. 3) and
palmitoylated (Fig. 1) protein in pfa3 cells.
We then analyzed the biochemical properties of the Pfa3
protein. Sizing of epitope-tagged Pfa3 indicates that the majority
of the protein is not part of a large complex (Fig. 3G); its
migration corresponds to its molecular weight. In agreement
with this, Pfa3 does not copurify other vacuolar proteins like
Ykt6, Vac8, or Vam3 under the selected conditions (Fig. 3H).
Thus, modification of Vac8 or regulation of Pfa3 via other
proteins may be mediated by a transient interaction of the
proteins.
Role of Pfa3 in Palmitoylation of SH4 Domains. Because Pfa3 is
involved in Vac8’s vacuolar localization and palmitoylation, we
asked whether its function could be assigned to recognition of the
SH4 domain, an N-terminal myristoylation motif linked to palmi-
toylated cysteines or a polybasic stretch.Wehave shown in a parallel
study that the first 16–18 aa of both Vac8 and Src kinase are
sufficient to direct GFP to the plasma membrane and to internal
membranes (K.S., L.E.P.D., H.H., T.J.L., and C.U., unpublished
work). In contrast to Vac8, the N-terminal Src sequence is not
palmitoylated but rather anchored by its myristatepolybasic
stretch. We used this system to determine whether Pfa3 is required
for their membrane localization. The two fusion proteins localize
similarly in wild-type or the swf1 cells (among the other DHHC
deletions). In the pfa3 mutant, however, both were found exclu-
sively at the plasma membrane (Fig. 4 A and B). The fact that both
types of SH4 domains require Pfa3 for their vacuole localization
[Src(1–16)-GFP is not palmitoylated] indicates that Pfa3 also func-
tions as a vacuole-sorting protein. Importantly, one reporter protein
containing the SH4 domain from the Leishmania highly acidic
surface protein B (HASPB, with a T6S mutation to allow for
myristoylation) is localized to intracellular membranes and the
plasmamembrane even in the pfa3 mutant (Fig. 4C). Regardless of
the localization, all cysteine-containing SH4 fusion proteins were
palmitoylated in vivo (Fig. 4D). Thus, Pfa3 confers localization of
fusion proteins with minimal sorting motifs to vacuole membranes.
Potentially, Pfa3 recognizes specific amino acids or structuralmotifs
in the Vac8 and Src sequence, which are absent in HASPB
(Fig. 4E).
Discussion
In this article, we describe the function of the vacuole-localized
DHHC protein, Pfa3. Pfa3 is required for efficient Vac8 local-
ization to vacuoles, consistent with its ability to promotes
palmitoylation in vitro upon reconstitution (28). Loss of Pfa3
leads to partial mislocalization of Vac8 to the cytosol and a
reduction in vacuole fusion. In pfa3 cells, the population of
Vac8 that is still localized to vacuoles is apparently palmitoy-
lated, indicating that other palmitoylation factors can substitute
for the loss of Pfa3 function. Our studies on Vac8 and Yck3
demonstrate that palmitoylation is affected by a complex net-
work of factors involved in protein sorting and, perhaps redun-
dantly, palmitoyl transfer.
Despite this complexity, the identification of Pfa3 adds to our
picture on palmitoylation at the vacuole. Previous studies iden-
tified the SNARE Ykt6 as a factor that promotes Vac8 palmi-
toylation in vitro (19). Antibodies to Ykt6 or the N-terminal
longin domain interfered with palmitoylation at an early stage of
fusion. Because in vitro palmitoylation required equimolar
amounts of Ykt6 to modify Vac8, we suggested that acylation
might occur by a nonenzymatic transfer mechanism (3, 19). Such
a mechanism has been suggested before and would explain
previous autoacylation data (31). Initial data on the biochemical
properties of DHHC-CRD protein pointed to the key function
of the DHHC motif in palmitoylation but also showed similar
acyl transfer properties as observed for Ykt6 (8, 10). However,
Fig. 4. Localization of minimal targeting constructs in yeast. Vac8(1–18)-GFP
(A), Src(1–16)-GFP (B), or HASPB.T6S(1–18)-GFP (HB.T6S) (C) were expressed in
BY wild-type or all DHHC deletion strains and analyzed by fluorescence
microscopy. Localization was similar in wild type and most DHHC deletion
strains (A–C Left). Only in pfa3 cells exclusive plasma membrane staining for
Vac8(1–18) and Src(1–16) was visible (A and B Right). (D) Palmitoylation of the
SH4(1–18)-GFP constructs. Palmitoylation of the indicated constructs was
determined as described in Fig. 3E. Total (6%) corresponds to the fraction of
lysate removed before the Neutravidin pull-down. Blots were decorated with
antibodies to GFP. (E) Alignment of the N-terminal 15 aa of the Vac8, Src, and
HASPB-T6S sequence.
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more recent studies on DHHC-dependent palmitoylation have
demonstrated enzymatic activity with turnover numbers ranging
between three per min for Ras (13) and two per h for Vac8 (31).
This rate is still very poor for Vac8, suggesting that additional
factors like Ykt6 and Sec18 increase efficiency of this reaction in
vitro. We previously showed that the palmitoylation activity for
Vac8 is present in a low-molecular-weight fraction prepared
from detergent-solubilized vacuoles (19). Because both Ykt6 and
Pfa3 migrate in this fraction, it is possible that both activities in
the detergent extract contributed to Vac8 palmitoylation in vitro
(32). Taken together, our data suggest that palmitoylation of
both Vac8 and Yck3 is not under the control of a single protein
but rather involves coordination among factors that regulate
their localization and accessibility to different palmitoylation
factors en route to the vacuole.
A protein’s palmitoylation does not necessarily need to occur
at its destination compartment. Swf1 appears to modify the
endosomal SNARE Tlg1 at the ER, the Golgi protein Akr1 acts
on the plasma membrane kinase Yck2, and the ER-localized
Erf2 palmitoylates Ras2, which is found at the Golgi and the
plasma membrane (7, 9, 10). The presence of palmitoyl transfer
proteinspalmitoyltransferases at multiple organelles raises the
important issue of how the specificity of palmitoylation reactions
is conferred. Potentially, DHHC proteins recognize not only a
sequence motif but also a substrate’s structure andor residence
in a certain complex, which would serve as a palmitoylation
signal. That the substrate provides the signal makes sense,
because palmitoyl transfer proteinsacyltransferases seem to
have overlapping activities that can compensate for one another.
According to our observations, none of the single DHHC
deletions resulted in mislocalization of Yck3 or Meh1, but both
proteins depend on palmitoylation for vacuole binding (ref. 15
and unpublished observations). Also, deletion of ERF2 still
permits partial Ras2 palmitoylation and localization (33), and
our data suggest that some Vac8 is palmitoylated in pfa3 cells.
In agreement with this postulate, Linder and colleagues (28)
detected residual palmitoylation of Vac8 by metabolic labeling
with [3H]palmitate in pfa3 cells. The localization of Vac8 to
pfa3 vacuoles is in striking contrast to the poor binding of a
Vac8 mutant that lacks its N-terminal cysteines and thus cannot
be palmitoylated (K.S., L.E.P.D., H.H., T.J.L., and C.U., un-
published work). We postulate that other proteins (DHHC
family members or Ykt6) support Vac8’s palmitoylation in pfa3
cells. In this mutant, Vac8 may not be palmitoylated at all three
possible cysteines or certain cysteines may also be more prone to
deacylation. Deacylation of certain cysteines, which would be
quenched during the N-ethylmaleimide treatment during the
biotin-switch procedure, might explain why we failed to detect
labeling of Vac8 in pfa3 cells using this method.
In summary, we presented evidence that Pfa3 is a factor that
affects palmitoylation of Vac8 on yeast vacuoles. Our data
suggest that Pfa3 targets proteins to the vacuole by recognizing
certain amino acids or structural motifs within the SH4 motif,
which then facilitates their efficient palmitoylation. Further work
will be needed to determine the specificity, regulation, and
redundancy of factors that function in the palmitoylation of
vacuolar proteins.
We thank Christoph Meiringer, Clemens Ostrowicz, and Karolina
Peplowska for comments; Gabriela Mu¨ller for expert technical assis-
tance; and Sean Munro and Michael Knop for plasmids. This work was
supported by Deutsche Forschungsgemeinschaft Grant UN1113-1
(Heisenberg Program), Sonderforschungsbereich 638, the EMBO
Young Investigator Program, and Fonds der Chemischen Industrie.
T.J.L. was the recipient of a predoctoral fellowship from the National
Science Foundation. L.E.P.D. was a recipient of a predoctoral fellowship
from the Boehringer Ingelheim Fonds.
1. Bonifacino, J. S. & Glick, B. S. (2004) Cell 116, 153–166.
2. Munro, S. (2005) Curr. Opin. Cell Biol. 17, 395–401.
3. Dietrich, L. E. & Ungermann, C. (2004) EMBO Rep. 5, 1053–1057.
4. Smotrys, J. E. & Linder, M. E. (2004) Annu. Rev. Biochem. 73, 559–587.
5. Magee, T. & Seabra, M. C. (2005) Curr. Opin. Cell Biol. 17, 190–196.
6. Linder, M. E. & Deschenes, R. J. (2003) Biochemistry 42, 4311–4320.
7. Valdez-Taubas, J. & Pelham, H. (2005) EMBO J. 24, 2524–2532.
8. Lobo, S., Greentree, W. K., Linder, M. E. & Deschenes, R. J. (2002) J. Biol.
Chem. 277, 41268–41273.
9. Dong, X., Mitchell, D. A., Lobo, S., Zhao, L., Bartels, D. J. & Deschenes, R. J.
(2003) Mol. Cell. Biol. 23, 6574–6584.
10. Roth, A. F., Feng, Y., Chen, L. & Davis, N. G. (2002) J. Cell Biol. 159, 23–28.
11. Fukata, M., Fukata, Y., Adesnik, H., Nicoll, R. A. & Bredt, D. S. (2004)Neuron
44, 987–996.
12. Huang, K., Yanai, A., Kang, R., Arstikaitis, P., Singaraja, R. R., Metzler, M.,
Mullard, A., Haigh, B., Gauthier-Campbell, C., Gutekunst, C. A., et al. (2004)
Neuron 44, 977–986.
13. Swarthout, J. T., Lobo, S., Farh, L., Croke,M. R., Greentree,W. K., Deschenes,
R. J. & Linder, M. E. (2005) J. Biol. Chem., in press.
14. Veit, M., Laage, R., Dietrich, L., Wang, L. & Ungermann, C. (2001) EMBO J.
20, 3145–3155.
15. Sun, B., Chen, L., Cao, W., Roth, A. F. & Davis, N. G. (2004) Mol. Biol. Cell
15, 1397–1406.
16. LaGrassa, T. J. & Ungermann, C. (2005) J. Cell Biol. 168, 401–414.
17. Dubouloz, F., Deloche, O., Wanke, V., Cameroni, E. & De Virgilio, C. (2005)
Mol. Cell 19, 15–26.
18. Gao, X. D., Wang, J., Keppler-Ross, S. & Dean, N. (2005) FEBS J. 272,
2497–2511.
19. Dietrich, L. E., Gurezka, R., Veit, M. & Ungermann, C. (2004) EMBO J. 23,
45–53.
20. Janke, C., Magiera, M. M., Rathfelder, N., Taxis, C., Reber, S., Maekawa, H.,
Moreno-Borchart, A., Doenges, G., Schwob, E., Schiebel, E. & Knop, M.
(2004) Yeast 21, 947–962.
21. Levine, T. P. & Munro, S. (2001) Mol. Biol. Cell 12, 1633–1644.
22. Denny, P. W., Gokool, S., Russell, D. G., Field, M. C. & Smith, D. F. (2000)
J. Biol. Chem. 275, 11017–11025.
23. Catlett, N. L. & Weisman, L. S. (1998) Proc. Natl. Acad. Sci. USA 95,
14799–14804.
24. Haas, A. & Wickner, W. (1996) Semin. Cell Dev. Biol. 7, 517–524.
25. Ungermann, C. & Wickner, W. (1998) EMBO J. 17, 3269–3276.
26. Drisdel, R. C. & Green, W. N. (2004) BioTechniques 36, 276–285.
27. Dietrich, L. E., LaGrassa, T. J., Rohde, J., Cristodero, M., Meiringer, C. T. &
Ungermann, C. (2005) J. Biol. Chem. 280, 15348–15355.
28. Smotrys, J. E., Schoenfish, M. J., Stutz, M. A. & Linder, M. E. (2005) J. Cell
Biol. 170, 1091–1099.
29. Wang, Y. X., Catlett, N. L. &Weisman, L. S. (1998) J. Cell Biol. 140, 1063–1074.
30. Haas, A., Conradt, B. & Wickner, W. (1994) J. Cell Biol. 126, 87–97.
31. Bizzozero, O. A., Bixler, H. A. & Pastuszyn, A. (2001) Biochim. Biophys. Acta
1545, 278–288.
32. Veit, M., Dietrich, L. E. & Ungermann, C. (2003) FEBS Lett. 540, 101–105.
33. Bartels, D. J., Mitchell, D. A., Dong, X. & Deschenes, R. J. (1999) Mol. Cell.
Biol. 19, 6775–6787.
Hou et al. PNAS  November 29, 2005  vol. 102  no. 48  17371
CE
LL
BI
O
LO
G
Y
